Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Observational, Prospective, Multicenter Study On Histoacryl Used For Embolization Of Middle Meningeal Artery (MMA) In Chronic Subdural Hematoma (CSDH) (HARMONY)

NCT07258069 is registered in ClinicalTrials.gov with Aesculap AG as lead sponsor.

NCT NCT07258069
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07258069 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Observational, Prospective, Multicenter Study On Histoacryl Used For Embolization Of Middle Meningeal Artery (MMA) In Chronic Subdural Hematoma (CSDH) (HARMONY)
Lead sponsor
Aesculap AG
Phase
Observational
Overall status
Recruiting
Start date
April 10, 2026
Completion date
August 31, 2027
Enrollment
178 (estimated)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

subdural hematoma, subdural hematoma, chronic